Stocks · Health care · Surgical & Medical Instruments & Apparatus

Bioventus Inc.

BVS Clue Score54
United States Fiscal year ends December CIK 0001665988 Results filed 2 Nov 2026

What the insiders did Net selling

By person

14 insiders · 3 transactions
1.4×

Robert E. Claypoole holds only 1.4 times base salary in stock. $1.19M of shares against $824.11K in salary for 2025.

Salary from the company's own proxy. The shares are what Robert E. Claypoole last reported holding, valued at $8.79, the price Class A Common Stock was last bought or sold at on the open market here, on 11 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Michelle McMurry-Heath
Director
—
$236.69K (2)
−$236.69K
77,279
0.114%
$679.02K
+60.3%
Guy P Nohra
Director
—
$75.66K (1)
−$75.66K
148,892
0.219%
$1.31M
+48.7%
William A Hawkins
Director
—
—
—
297,640
0.439%
$2.62M
+28.6%
Mark Leonard Singleton
SVP & CFO
—
—
—
177,333
0.261%
$1.56M
+108.9%
Anthony D'Adamio
SVP & General Counsel
—
—
—
153,655
0.226%
$1.35M
+60.8%
Susan M Stalnecker
Director
—
—
—
138,239
0.204%
$1.21M
+74.0%
Robert E Claypoole
President and CEO
—
—
—
135,944
0.200%
$1.19M
—
Guido J Neels
Director
—
—
—
117,523
0.173%
$1.03M
+100.0%
Martin P Sutter
Director
—
—
—
117,523
0.173%
$1.03M
+100.0%
John A. Bartholdson
Director
—
—
—
111,902
0.165%
$983.24K
+145.7%
Mary Kay Ladone
Director
—
—
—
111,263
0.164%
$977.62K
+112.0%
Pat Beyer
Director
—
—
—
108,718
0.160%
$955.26K
+117.7%
Katrina J Church
SVP & Chief Compliance Officer
—
—
—
64,164
0.095%
$563.78K
+55.7%
Philip G. Cowdy
Director
—
—
—
43,982
0.065%
$386.45K
+275.9%